Atlas Trials

A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

Clinical trial NCT06708611 · WITHDRAWN

Trial details

NCT number
NCT06708611
Sponsor
Sarfez Pharmaceuticals, Inc.
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure
Start date
2025-01-15
Primary completion
2025-03-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.